Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’
India’s Supreme Court has raised concerns over high mark‑ups on cancer treatments, describing the price gap as ‘carnage.’ Petitioners have asked the court to intervene and set regulations to lower costs of oncology drugs, medical equipment and generic medicines, aiming to improve affordability for patients. The court’s scrutiny signals potential policy action on drug pricing.